Attribute | Details |
---|---|
Active Ingredients | Sildenafil Citrate 100mg, Duloxetine 30mg |
Indications | Erectile Dysfunction, Premature Ejaculation |
Form | Tablet |
Administration | Oral |
Manufacturer | Sunrise Remedies |
Learn More |
The pharmacokinetic profile of Malegra DXT reveals critical insights into its absorption and elimination. Malegra DXT combines Sildenafil 100mg and Duloxetine 30mg. After oral administration, sildenafil is rapidly absorbed. It reaches peak plasma concentrations in 30 to 120 minutes. The bioavailability is approximately 41%. Meanwhile, duloxetine exhibits a delayed absorption. It reaches maximum concentration in approximately 6 hours.
Sildenafil undergoes hepatic metabolism, primarily via the CYP3A4 and CYP2C9 pathways. The elimination half-life is around 4 hours. Duloxetine, primarily metabolized by CYP1A2 and CYP2D6, has a half-life of approximately 12 hours. Both components are primarily excreted via urine. The pharmacokinetics may vary based on factors like age, renal function, and concomitant medications.
Proper usage of Malegra DXT 100mg is crucial for effectiveness and safety. The recommended dose is one tablet daily, administered with water. Timing is essential; intake should occur about an hour before sexual activity. It can be taken with or without food, but a high-fat meal may delay sildenafil absorption.
Patients must adhere to the prescribed dosage and frequency. Overuse can heighten adverse effects. The combination of sildenafil and duloxetine caters to erectile dysfunction and premature ejaculation. Alterations to dosing regimens require medical guidance. This minimizes risks of overdose and interaction.
Malegra DXT mandates cautious use. Cardiovascular status must be assessed due to potential cardiac risks associated with sildenafil. Patients with a history of cardiac events require stringent monitoring. Caution is advised for those with hepatic or renal impairments.
Potential drug interactions necessitate medical consultation. Nitrate drugs for chest pain and certain antihypertensives can result in critical interactions. Alcohol may exacerbate side effects like dizziness and headaches. Driving or operating machinery post-consumption is inadvisable.
The safety of Malegra DXT during pregnancy is not established. It is contraindicated for use in pregnant women. Duloxetine crosses the placenta and can affect fetal development. Sildenafil’s effects on fetal circulation require caution.
Lactating mothers should also avoid this medication. Duloxetine is excreted in breast milk and may impact a nursing infant. Professional consultation is critical when considering any medication during these periods.
Toxicity from Malegra DXT can manifest from overdose or interactions. Symptoms include severe hypotension, syncope, or prolonged erections. Unaddressed, priapism can cause permanent damage. Prompt medical intervention is vital.
Supportive treatment is the primary response for toxicity. Monitoring vital signs and providing symptomatic care is essential. Activated charcoal may be considered to prevent further absorption if within the ingestion window. Monitoring and intervention help mitigate the risks associated with toxicity.
Information taken from: